Multinational study exploring patients' perceptions of side-effects induced by chemo-radiotherapy

Area of Science:

• Oncology
• Radiotherapy
• Pharmacology

Background:

• Chemotherapy and radiotherapy are standard cancer treatments.
• Cisplatin is a common chemotherapy agent used in combination with radiotherapy.
• Understanding treatment-induced side effects is crucial for patient care.

Purpose of the Study:

• To prospectively evaluate the incidence and severity of side effects.
• To assess patient perceptions of side effects from radiotherapy and cisplatin.
• To compare symptom burden before and during treatment.

Main Methods:

• Multinational survey of cancer patients receiving radiotherapy and weekly cisplatin.
• Questionnaires administered pre-treatment and after three weeks of treatment.
• Comparison of symptom frequency, severity, and patient rankings.

Main Results:

• Mean number of symptoms increased from 18 to 24 during treatment.
• Most feared symptoms shifted from non-physical to physical after three weeks.
• Nausea remained a significant issue despite antiemetic prophylaxis.

Conclusions:

• Patients experience a shift towards physical symptoms during combined chemo-radiotherapy.
• Head and neck and gynecological cancer patients report significant symptom burden.
• Further research into side effect prevention is essential.